Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Cancer.Net. Pancreatic Cancer: Statistics. American Society of Clinical Oncology. ASCO; 2018.
   Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.3193730350310
   PubMed Web of Science ®Google Scholar
• Kleeff J, Costello E, Jackson R, et al. The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer. Br J Cancer. 2016;115(7):887–894. doi:10.1038/bjc.2016.27727584663
   PubMed Web of Science ®Google Scholar
• Walter U, Kohlert T, Rahbari NN, Weitz J, Welsch T. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2014;21(4):1082–1089. doi:10.1245/s10434-013-3415-624322532
   PubMed Web of Science ®Google Scholar
• Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. Prevalence and clinical profile of pancreatic cancer–associated diabetes mellitus. Gastroenterology. 2008;134(4):981–987. doi:10.1053/j.gastro.2008.01.03918395079
   PubMed Web of Science ®Google Scholar
• Boursi B, Finkelman B, Giantonio BJ, et al. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes. Gastroenterology. 2017;152(4):840–850.e3. doi:10.1053/j.gastro.2016.11.04627923728
   PubMed Web of Science ®Google Scholar
• Abudawood M. Diabetes and cancer: a comprehensive review. J Res Med Sci. 2019;24(1):94. doi:10.4103/jrms.JRMS_242_1931741666
   PubMed Web of Science ®Google Scholar
• Mizuno S, Nakai Y, Isayama H, et al. Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer. Pancreatology. 2013;13(3):285–289. doi:10.1016/j.pan.2013.03.01323719602
   PubMed Web of Science ®Google Scholar
• Kaleru T, Vankeshwaram VK, Maheshwary A, Mohite D, Khan S. Diabetes mellitus in the middle-aged and elderly population (>45 years) and its association with pancreatic cancer: an updated review. Cureus. 2020;12(6):e8884. doi:10.7759/cureus.888432742851
   PubMed Web of Science ®Google Scholar
• Harry K, Kein-Leong Y. Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study. J Diabetes Metab Disord. 2018;17(2):247–252. doi:10.1007/s40200-018-0366-230918860
   PubMed Web of Science ®Google Scholar
• Tan Z, Xu J, Zhang B, Shi S, Yu X, Liang C. Hypoxia: a barricade to conquer the pancreatic cancer. Cell Mol Life Sci. 2020;77(16):3077–3083. doi:10.1007/s00018-019-03444-331907561
   PubMed Web of Science ®Google Scholar
• Onozuka H, Tsuchihara K, Esumi H. Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs. Cancer Sci. 2011;102(5):975–982. doi:10.1111/j.1349-7006.2011.01880.x21255190
   PubMed Web of Science ®Google Scholar
• Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352):eaan2507. doi:10.1126/science.aan250728818916
   PubMed Web of Science ®Google Scholar
• Dassah M, Almeida D, Hahn R, Bonaldo P, Worgall S, Hajjar KA. Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells. J Cell Sci. 2014;127(4):828–844. doi:10.1242/jcs.13780224357721
   PubMed Web of Science ®Google Scholar
• Owusu-Ansah KG, Song G, Chen R, et al. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer. Int J Oncol. 2019;55(2):391–404. doi:10.3892/ijo.2019.482531268154
   PubMed Web of Science ®Google Scholar
• Pontén F, Jirström K, Uhlen M. The Human Protein Atlas—a tool for pathology. J Pathol. 2008;216(4):387–393. doi:10.1002/path.244018853439
   PubMed Web of Science ®Google Scholar
• Hou T, Tong C, Kazobinka G, et al. Expression of COL6A1 predicts prognosis in cervical cancer patients. Am J Transl Res. 2016;8(6):2838–2844.27398167
   PubMed Web of Science ®Google Scholar
• Zhu Y-P, Wan F-N, Shen Y-J, Wang H-K, Zhang G-M, Ye D-W. Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth. Oncotarget. 2015;6(16):14488–14496. doi:10.18632/oncotarget.369725895032
   PubMedGoogle Scholar
• Chiu K-H, Chang Y-H, Wu Y-S, Lee S-H, Liao P-C. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. J Proteome Res. 2011;10(3):1110–1125. doi:10.1021/pr100872421186846
   PubMed Web of Science ®Google Scholar
• Jian Z, Cheng T, Zhang Z, et al. Glycemic variability promotes both local invasion and metastatic colonization by pancreatic ductal adenocarcinoma. Cell Mol Gastroenterol Hepatol. 2018;6(4):429–449. doi:10.1016/j.jcmgh.2018.07.00330258965
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Principe DR, Rana A. Updated risk factors to inform early pancreatic cancer screening and identify high risk patients. Cancer Lett. 2020;485:56–65. doi:10.1016/j.canlet.2020.04.02232389710
   PubMed Web of Science ®Google Scholar
• Aleksandrovski YA. Molecular mechanisms of the cross-impact of pathological processes in combined diabetes and cancer. Research and clinical aspects. Biochemistry (Mosc). 2002;67(12):1329–1346. doi:10.1023/a:102180180840512600262
   PubMed Web of Science ®Google Scholar
• Schwartz L, Supuran CT, Alfarouk KO. The Warburg effect and the hallmarks of cancer. Anticancer Agents Med Chem. 2017;17(2):164–170. doi:10.2174/187152061666616103114330127804847
   PubMed Web of Science ®Google Scholar
• Schwartz SS, Grant SFA, Herman ME. Intersections and clinical translations of diabetes mellitus with cancer promotion, progression and prognosis. Postgrad Med. 2019;131(8):597–606. doi:10.1080/00325481.2019.165735831419922
   PubMed Web of Science ®Google Scholar
• Hessmann E, Buchholz SM, Demir IE, et al. Microenvironmental determinants of pancreatic cancer. Physiol Rev. 2020;100(4):1707–1751. doi:10.1152/physrev.00042.201932297835
   PubMed Web of Science ®Google Scholar
• Sato T, Takano R, Tokunaka K, et al. Type VI collagen α1 chain polypeptide in non-triple helical form is an alternative gene product of COL6A1. J Biochem. 2018;164(2):173–181. doi:10.1093/jb/mvy04029659864
   PubMed Web of Science ®Google Scholar
• Voiles L, Lewis DE, Han L, et al. Overexpression of type VI collagen in neoplastic lung tissues. Oncol Rep. 2014;32(5):1897–1904. doi:10.3892/or.2014.343825176343
   PubMed Web of Science ®Google Scholar
• Fujita A, Sato JR, Festa F, et al. Identification of COL6A1 as a differentially expressed gene in human astrocytomas. Genet Mol Res. 2008;7(2):371–378. doi:10.4238/vol7-2gmr43218551403
   PubMed Web of Science ®Google Scholar
• Magruder JT, Elahi D, Andersen DK. Diabetes and pancreatic cancer: chicken or egg? Pancreas. 2011;40(3):339–351. doi:10.1097/MPA.0b013e318209e05d21412116
   PubMed Web of Science ®Google Scholar
• Hou T, Tong C, Kazobinka G, et al. Expression of COL6A1 predicts prognosis in cervical cancer patients. Am J Transl Res. 2019;8(6):2838–2844.
   Google Scholar
• Wan F, Wang H, Shen Y, et al. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients. Oncotarget. 2015;6(29):27378–27387. doi:10.18632/oncotarget.486026317545
   PubMedGoogle Scholar